Ikarian Capital, LLC
CIK 1778253 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- ARGX7.26%
- CRNX6.62%
- SLNO6.50%
- XHB5.23%
- BBIO5.22%
- NUVL5.20%
- SLRN4.06%
- AMLX3.53%
- SRPT3.50%
- ANNX3.29%
Share classes counted separately50.41%
Portfolio value by quarter
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | ARGXARGENX SE - ADRSPONSORED ADR View history and evidence | $26.54M | 7.26% | 70.00K shares | — | ↗▾ | |
| 02 | CRNXCRINETICS PHARMACEUTICALS IN View history and evidence | $24.21M | 6.62% | 680.37K shares | — | ↗▾ | |
| 03 | SLNOSOLENO THERAPEUTICS INC View history and evidence | $23.76M | 6.50% | 590.24K shares | — | ↗▾ | |
| 04 | XHBSS SPDR S&P HOMEBLDRS ETFS&P HOMEBUILD View history and evidence | $19.13M | 5.23% | 200.00K shares | — | ↗▾ | |
| 05 | BBIOBRIDGEBIO PHARMA INC View history and evidence | $19.10M | 5.22% | 473.13K shares | — | ↗▾ | |
| 06 | NUVLNUVALENT INC-A View history and evidence | $19.00M | 5.20% | 258.14K shares | — | ↗▾ | |
| 07 | SLRNACELYRIN INC View history and evidence | $14.85M | 4.06% | 1.99M shares | — | ↗▾ | |
| 08 | AMLXAMYLYX PHARMACEUTICALS INC View history and evidence | $12.92M | 3.53% | 877.50K shares | — | ↗▾ | |
| 09 | SRPTSAREPTA THERAPEUTICS INC View history and evidence | $12.79M | 3.50% | 132.64K shares | — | ↗▾ | |
| 10 | ANNXANNEXON INC View history and evidence | $12.03M | 3.29% | 2.65M shares | — | ↗▾ |
Options overlay 58
$702.43M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
KRYSKRYSTAL BIOTECH INC View history and evidence | Put | 412.00K | $51.11M | ▾ | |
CYTKCYTOKINETICS INCCOM NEW View history and evidence | Call | 603.50K | $50.39M | ▾ | |
XBISS SPDR S&P BIOTECH ETFS&P BIOTECH View history and evidence | Put | 550.00K | $49.11M | ▾ |
3 / 58 options · preview only
Exited positions 55
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| SPY SS SPDR S&P 500 ETF TRUST-US | Put | — | — | SEC filing ↗ | |
| QQQ INVESCO QQQ TRUST SERIES 1 | Put | — | — | SEC filing ↗ | |
| AKRO AKERO THERAPEUTICS INC | Put | — | — | SEC filing ↗ |
3 / 55 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1778253 · Period Dec 31, 2023
Data loaded Oct 15, 2026 · First reported Feb 14, 2024
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 1067984222
}Research all 136 reported holdings.
This page includes 30 of 136 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 136 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_institutional_holdings
{"action":"portfolio","cik":"1778253","quarter":"2023Q4","page_size":100}
akkru_institutional_holdings
{"action":"history","cik":"1778253","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.